The fluctuations of hepatitis C virus RNA and IgM anti-HCV (core) serum levels correlate with those of alanine aminotransferases during the hepatitis relapses of patients treated with interferon
β Scribed by F. Negro; M. L. Abate; A. Mondardini; M. Baldi; G. Leandro; S. Lombardi; L. Wolfe; J. C. Ryff; G. Verme; M. R. Brunetto; R Bonino
- Book ID
- 119836549
- Publisher
- John Wiley and Sons
- Year
- 1995
- Tongue
- English
- Weight
- 329 KB
- Volume
- 2
- Category
- Article
- ISSN
- 1352-0504
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Detection and quantification of hepatitis C virus (HCV) RNA levels by using the standardized qualitative Amplicorβ’ HCV and quantitative Amplicor HCV Monitorβ’ assays (Roche Molecular Systems) were evaluated in 48 patients with chronic hepatitis C treated with interferon. Results were compared with an
The incidence and clinical meaning of elevated alanine aminotransferase (ALT) in chronic hepatitis C patients who are hepatitis C virus (HCV)-RNA negative during pegylated interferon (PEG-IFN) and ribavirin therapy have not been completely characterized. In this study our aim was to assess the incid
## Background: The relationship between the recurrence of hepatocellular carcinoma (hcc) and the serum alanine aminotransferase (alt) level was studied in hepatectomized patients with hepatitis c virus (hcv)-associated cirrhosis and hcc. ## Methods: Twenty-six hepatectomized patients with hcv-ass
## Abstract The use of two new assays was evaluated for predicting the response to interferon (IFN) therapy in patients with chronic hepatitis C. The genotype of hepatitis C virus (HCV) was establishe by an enzymeβlinked immunosorbent assay based on genotypeβspecific recombinant peptides of the NS4